The Cav-1, hepcidin, ferritin, and Tf concentrations could individually highlight the differences between the healthy participants and patients with NAFLD in the high AUROCs (Fig. 7b). This evidence concerns the gene CAV1 and metabolic dysfunction-associated steatotic liver disease.